A rapid flow cytometric method for the detection of intracellular cyclooxygenases in human whole blood monocytes and a COX-2 inducible human cell line

Journal of Immunological Methods

Volumn 274, Issue 1-2, 2003, Pages 93-104

  Ruitenberg, Joyce J ^a   Waters, Cory A ^a  

^a BD BIOSCIENCES   (United States)

Author keywords

Cyclooxygenase 1; Cyclooxygenase 2; Flow cytometry; Intracellular staining; Monoclonal antibody

Indexed keywords

CD14 ANTIGEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOTOXIN; MONOCLONAL ANTIBODY; REAGENT; SAPONIN;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; BLOOD; BLOOD ANALYSIS; CELL ASSAY; CELL LINE; CELL MEMBRANE PERMEABILITY; CELL STRAIN; CONTROLLED STUDY; ENZYME ASSAY; ENZYME INDUCTION; ENZYME SPECIFICITY; EVALUATION; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; MONOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STAINING; TECHNIQUE;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CELL LINE; CELL MEMBRANE PERMEABILITY; COLOR; CULTURE MEDIA, SERUM-FREE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOPLASM; FLOW CYTOMETRY; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; MONOCYTES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SAPONINS; TIME FACTORS;

BOVINAE;

EID: 0037374392     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(02)00507-0     Document Type: Article

References (32)

1. Berg J., Christoph T., Widerna M., Bodenteich A. Isoenzyme-specific cyclooxygenase inhibitors: a whole cell assay system using the human erythroleukemic cell line HEL and the human monocytic cell line MonoMac 6. J. Pharmacol. Toxicol. Methods. 37:1997;179-186.
2. Chan G., Boyle J.O., Yang E.K., Zhang F., Sacks P.G., Shah J.P., Edelstein D., Soslow R.A., Koki A.T., Woerner B.M., Masferrer J.L., Dannenberg A.J. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res. 59:1999;991-994.
3. 2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res. 59:1999;4574-4577.
4. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferenbach S., DuBois R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 107:1994;1183-1188.
5. Elder D.J.E., Halton D.E., Hague A., Paraskevs C. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin. Cancer Res. 3:1997;1679-1683.
6. Fletcher B.S., Kujubu D.A., Perrin D.M., Herschman H.R. Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. J. Biol. Chem. 267:1992;4338-4344.
7. Giuliano F., Warner T.D. Ex vivo assay to determine the cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs. Br. J. Pharmacol. 126:1999;1824-1839.
8. Glasgow W.C., Afshari C.A., Barrett J.C., Eling T.E. Modulation of the epidermal growth factor mitogenic response by metabolites of linoleic and arachidonic acid in Syrian hamster embryo fibroblast. Differential effects in tumor suppressor gene (+) and (-) phenotypes. J. Biol. Chem. 267:1992;10771-10779.
9. Herschman H.R. Prostaglandin synthase 2. Biochim. Biophys. Acta. 1299:1996;125-140.
10. Iyer V.R., Eisen M.B., Ross D.T., Schuler G., Moore T., Lee J.C.F., Trent J.M., Staudt L.M., Hudson J. Jr., Boguski M.S., Lashkari D., Shalon D., Dotstein D., Brown P.O. The transcriptional program in the response of human fibroblast to serum. Science. 283:1999;83-87.
11. Kamitani H., Geller M., Eling T. Expression of 15-lipoxygenase by human colorectal carcinoma Caco-2 cells during apoptosis and cell differentiation. J. Biol. Chem. 273:1998;21569-21577.
12. Kang R.Y., Freire-Moar J., Sigal E., Chu C.O. Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis. Br. J. Rheumatol. 35:1996;711-718.
13. Kulkarni S., Rader J.S., Zhang F., Liapis H., Koki A.T., Masferrer J.L., Subbaramaiah K., Dannenberg A.J. Cyclooxygenase-2 is overexpressed in human cervical cancer. Clin. Cancer Res. 7:2001;429-434.
14. Litherland S.A., Xie X.T., Hutson A.D., Wasserfall C., Whittaker D.S., She J.-X., Hofig A., Dennis M.A., Fuller K., Cook R., Schatz D., Moldawer L.L., Clare-Salzler M.J. Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus. J. Clin. Invest. 104:1999;515-523.
15. Maloney C.G., Kutchera W.A., Albertine K.H., McIntyre T.M., Prescott S.M., Zimmerman G.A. Inflammatory agonists induce cyclooxygenase type 2 expression by human neutrophils. J. Immunol. 106:1998;1402-1410.
16. Mardini I.A., FitzGerald G.A. Selective inhibitors of cyclooxygenase-2. Mol. Interv. 1:2001;30-38.
17. Masferrer J.L., Zweifel B.S., Manning P.T., Hauser S.D., Leahy K.M., Smith W.G., Isakson P.C., Seibert K. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. U. S. A. 91:1994;3228-3232.
18. Masferrer J.L., Leahy K.M., Koki A.T., Zweifel B.S., Settle S.L., Woerner B.M., Edwards D.A., Flickinger A.G., Moore R.J., Seibert K. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res. 60:2000;1306-1311.
19. Molina M.A., Sitja-Arnau M., Lemoine M.G., Frazier M.L., Sinicrope F.A. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Res. 59:1999;4356-4362.
20. + T cells. Cytometry. 40:2000;60-68.
21. Okami J., Yamamoto H., Fujiwara Y., Tsujie M., Kondo M., Noura S., Oshima S., Nagano H., Dono K., Umeshita K., Ishikawa O., Sakon M., Matsuura N., Nakamori S., Monden M. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. Clin. Cancer Res. 5:1999;2018-2024.
22. Pasinetti G.M. Cyclooxygenase and Alzheimer's disease: implications for preventive initiatives to slow the progression of clinical dementia. Arch. Gerontol. Geriatr. 33:2001;13-28.
23. Patrignani P., Panara M.R., Greco A., Fusco O., Natoli C., Iacobelli S., Cipollone F., Ganci A., Creminon C., Maclouf J.et al. Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J. Pharmacol. Exp. Ther. 271:1994;1705-1712.
24. Reddy B.S., Hirose Y., Lubet R., Steele V., Kelloff G., Paulson S., Seibert K., Rao C.V. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, Celecoxib, administered during different stages of carcinogenesis. Cancer Res. 60:2000;293-297.
25. Sawaoka H., Kawano S., Tsuji S., Tsuji M., Sun W., Gunawan E.S., Hori M. Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa. Prostaglandins Leukot. Essent. Fat. Acids. 59:1998;313-316.
26. Singer I.I., Kawka D.W., Schloemann S., Tessner T., Riehl T., Stenson W.F. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology. 115:1998;297-306.
27. Smith W.L., Garavito R.M., DeWitt D.L. Prostaglandin endoperoxide H synthases (Cyclooxygenases)-1 and -2. J. Biol. Chem. 271:1996;33157-33160.
28. Spencer A.G., Woods J.W., Arakawa T., Singer I.I., Smith W.L. Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy. J. Biol. Chem. 273:1998;9886-9893.
29. 2 in human prostatic carcinoma cells. Br. J. Cancer. 75:1997;1111-1118.
30. Uefuji K., Ichikura T., Mochizuki H., Shinomiya N. Expression of cyclooxygenase-2 protein in gastric adenocarcinoma. J. Surg. Oncol. 69:1998;168-172.
31. Uefuji K., Ichikura T., Mochizuki H. Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer. Clin. Cancer Res. 6:2000;135-138.
32. Warner T.D., Guiliano F., Vojnovic I., Bukasa A., Mitchell J.D., Vane J.R. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc. Natl. Acad. Sci. U. S. A. 96:1999;7563-7568.